Tags: sleeping drug | circadian rhythm disorder | tasimelteon | Non-24

New Sleep Drug Gets FDA Preliminary OK

Tuesday, 12 Nov 2013 12:13 PM


An experimental sleep disorder drug made by Vanda Pharmaceuticals Inc is safe and effective enough to warrant approval, a U.S. Food and Drug Administration review found.
The report, posted on the FDA's website on Tuesday, comes two days ahead of a meeting of outside medical experts who will discuss the drug and recommend whether or not it should be approved. The FDA is not bound to follow the advice of its advisory panels but typically does so.
The drug, tasimelteon, is designed to treat Non-24-Hour Disorder, or Non-24, a circadian rhythm disorder that is most commonly found in the totally blind and can cause disrupted nighttime sleep patterns and excessive daytime sleepiness.

© 2017 Thomson/Reuters. All rights reserved.

 
1Like our page
2Share
Health-News
An experimental sleep disorder drug made by Vanda Pharmaceuticals Inc is safe and effective enough to warrant approval, a U.S. Food and Drug Administration review found. The report, posted on the FDA's website on Tuesday, comes two days ahead of a meeting of outside medical...
sleeping drug,circadian rhythm disorder,tasimelteon,Non-24
112
2013-13-12
Tuesday, 12 Nov 2013 12:13 PM
Newsmax Inc.
 

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved